✉news HealthMental Health first seen 8 h ago, last 6 h ago, peak #20
FDA approves AbbVie's Parkinson's drug from Cerevel deal
Original: AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
AbbVie has won US Food and Drug Administration approval for a Parkinson's disease treatment developed through its $8.7 billion acquisition of Cerevel Therapeutics. The approval validates the company's large bet on neurology and gives AbbVie a new product in a market where its flagship franchise faces eventual competition. Industry observers are watching how quickly the drug can reach patients and generate revenue.
Why now: The FDA decision is a major commercial and strategic milestone for AbbVie's neurology business.
Rank over time, top of the chart is #1. 2 snapshots from 8 h ago to 6 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/236741